207 related articles for article (PubMed ID: 33388379)
21. Targets and Mechanism Used by Cinnamaldehyde, the Main Active Ingredient in Cinnamon, in the Treatment of Breast Cancer.
Liu Y; An T; Wan D; Yu B; Fan Y; Pei X
Front Pharmacol; 2020; 11():582719. PubMed ID: 33536908
[No Abstract] [Full Text] [Related]
22. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease.
Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L
J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853
[TBL] [Abstract][Full Text] [Related]
23. 2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction.
Hwa JS; Jin YC; Lee YS; Ko YS; Kim YM; Shi LY; Kim HJ; Lee JH; Ngoc TM; Bae KH; Kim YS; Chang KC
J Ethnopharmacol; 2012 Jan; 139(2):605-15. PubMed ID: 22179023
[TBL] [Abstract][Full Text] [Related]
24. Network pharmacology and experimental validation to explore the molecular mechanisms of Bushen Huoxue for the treatment of premature ovarian insufficiency.
Cao Y; Chen Y; Wang P; Lu J; Han X; She J
Bioengineered; 2021 Dec; 12(2):10345-10362. PubMed ID: 34753385
[TBL] [Abstract][Full Text] [Related]
25. Aqueous cinnamon extract (ACE-c) from the bark of Cinnamomum cassia causes apoptosis in human cervical cancer cell line (SiHa) through loss of mitochondrial membrane potential.
Koppikar SJ; Choudhari AS; Suryavanshi SA; Kumari S; Chattopadhyay S; Kaul-Ghanekar R
BMC Cancer; 2010 May; 10():210. PubMed ID: 20482751
[TBL] [Abstract][Full Text] [Related]
26. A network pharmacology approach and experimental validation to investigate the anticancer mechanism of Qi-Qin-Hu-Chang formula against colitis-associated colorectal cancer through induction of apoptosis via JNK/p38 MAPK signaling pathway.
Wu Y; Fang Y; Li Y; Au R; Cheng C; Li W; Xu F; Cui Y; Zhu L; Shen H
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117323. PubMed ID: 37852337
[TBL] [Abstract][Full Text] [Related]
27. Study on the Mechanism of Liuwei Dihuang Pills in Treating Parkinson's Disease Based on Network Pharmacology.
Lin D; Zeng Y; Tang D; Cai Y
Biomed Res Int; 2021; 2021():4490081. PubMed ID: 34746302
[TBL] [Abstract][Full Text] [Related]
28. Network Pharmacology-Based and Molecular Docking-Based Analysis of Suanzaoren Decoction for the Treatment of Parkinson's Disease with Sleep Disorder.
Liu YY; Yu LH; Zhang J; Xie DJ; Zhang XX; Yu JM
Biomed Res Int; 2021; 2021():1752570. PubMed ID: 34660782
[TBL] [Abstract][Full Text] [Related]
29. Network pharmacology-based screening of the active ingredients and mechanisms of Huangqi against aging.
Lan S; Duan J; Zeng N; Yu B; Yang X; Ning H; Huang Y; Rao Y
Medicine (Baltimore); 2021 Apr; 100(17):e25660. PubMed ID: 33907130
[TBL] [Abstract][Full Text] [Related]
30. The mechanisms of action of WeiChang'An Pill (WCAP) treat diarrhoea-predominant irritable bowel syndrome (IBS-D) using network pharmacology approach and in vivo studies.
Chen Y; Chu F; Lin J; Su Z; Liao M; Li T; Li Y; Johnson N; Zheng H; Ding X
J Ethnopharmacol; 2021 Jul; 275():114119. PubMed ID: 33862102
[TBL] [Abstract][Full Text] [Related]
31. Systematic Evaluation of the Mechanisms of Mulberry Leaf (Morus alba Linne) Acting on Diabetes Based on Network Pharmacology and Molecular Docking.
Wu Q; Hu Y
Comb Chem High Throughput Screen; 2021; 24(5):668-682. PubMed ID: 32928080
[TBL] [Abstract][Full Text] [Related]
32. Chemical profiling and identification of anti-osteoporosis chemical-markers of
Zhao S; Wu Y; Qian Y; Qian Y; Xue S; Chen J; Zeng Q; Gu M
Nat Prod Res; 2023 Jun; 37(11):1902-1906. PubMed ID: 36098221
[No Abstract] [Full Text] [Related]
33. Exploration of the mechanism of Zisheng Shenqi decoction against gout arthritis using network pharmacology.
Li WH; Han JR; Ren PP; Xie Y; Jiang DY
Comput Biol Chem; 2021 Feb; 90():107358. PubMed ID: 33243703
[TBL] [Abstract][Full Text] [Related]
34. [Safety evaluation of Tibetan medicine Qishiwei Zhenzhu Pills based on serum pharmacochemistry and network pharmacology].
Yan ZY; Zong YH; Zhang CF; Wu LL; Qin LL; Liu TH
Zhongguo Zhong Yao Za Zhi; 2023 May; 48(9):2538-2551. PubMed ID: 37282883
[TBL] [Abstract][Full Text] [Related]
35. Uncovering the Mechanism of Astragalus membranaceus in the Treatment of Diabetic Nephropathy Based on Network Pharmacology.
Guo MF; Dai YJ; Gao JR; Chen PJ
J Diabetes Res; 2020; 2020():5947304. PubMed ID: 32215271
[TBL] [Abstract][Full Text] [Related]
36. Research on the Mechanism of Qushi Huayu Decoction in the Intervention of Nonalcoholic Fatty Liver Disease Based on Network Pharmacology and Molecular Docking Technology.
Gao SS; Sun JJ; Wang X; Hu YY; Feng Q; Gou XJ
Biomed Res Int; 2020; 2020():1704960. PubMed ID: 33204683
[TBL] [Abstract][Full Text] [Related]
37. ZW290 Increases Cold Tolerance by Inducing Thermogenesis via the Upregulation of Uncoupling Protein 1 in Brown Adipose Tissue In Vitro and In Vivo.
Wang N; Lu HY; Li X; Du YJ; Meng WH; Ding HW; Zhao QC
Lipids; 2019 May; 54(5):265-276. PubMed ID: 31087415
[TBL] [Abstract][Full Text] [Related]
38. Use of Network Pharmacology to Investigate the Mechanism of the Compound Xuanju Capsule in the Treatment of Rheumatoid Arthritis.
Wei W; Lu W; Chen X; Yang Y; Zheng M
Biomed Res Int; 2021; 2021():5568791. PubMed ID: 34414237
[TBL] [Abstract][Full Text] [Related]
39. Uncovering the protective mechanism of Taohong Siwu decoction against diabetic retinopathy via HIF-1 signaling pathway based on network analysis and experimental validation.
Wang L; Li S; Wang L; Lin K; Du J; Miao W; Zhang L
BMC Complement Med Ther; 2020 Oct; 20(1):298. PubMed ID: 33023593
[TBL] [Abstract][Full Text] [Related]
40. [Mechanism of Qingwei Powder in treatment of periodontitis based on UPLC-Q-TOF-MS, GC-MS, network pharmacology and molecular docking].
Meng Y; Jiang ZT; Yan GJ; Shen J; Sun KP; Wang YY; Cao JN; Xia MY; Pan JH
Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2778-2787. PubMed ID: 35718498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
